HTN 180 Px
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
Other Combinations
Product Type
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Motherwort | 290 mg | — |
| Hawthorn | 200 mg | — |
| Passionflower | 200 mg | — |
| European Mistletoe | 100 mg | — |
| Proprietary Blend | 24 mg | — |
| Vitexin | 2.5 mg | — |
Label Claims — Verification
❓
Structure/Function
All Other (97% of products)
Structure/Function (74% of products)
Target Groups
Vegan
Vegetarian
Adult (18 - 50 Years)
Organic
Dairy Free
Product Information
🧪 Formulation Notes
Regular strength Blood pressure support Already within normal range
Organic Certified Organic Herbs and Certified Organic
Vegan
Additional Information
Original
Organic Certified
Product Details
DSLD Entry Date
2023-08-23
Product Type
Other Combinations
Form
Capsule
Brand
Restorative Formulations
DSLD ID
299236
Data Updated
2026-04-11
Research Evidence
10
Research Sources
52
Avg Quality Score
5
Meta Analysis
3
Rct
1
Systematic Review
1
Other
B
Cancer-related fatigue in patients treated with mistletoe extracts: a systematic review and meta-analysis
B
A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings
C
Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review
C
Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL)
C
Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis
C
Cancer Patients' Experiences of Using Mistletoe (Viscum album): A Qualitative Systematic Review and Synthesis
C
Survival of Cancer Patients Treated with Non-Fermented Mistletoe Extract: A Systematic Review and Meta-Analysis
C
Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study
C
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.